Back

Pharmacogenomic predictors of drug response and choice in dyslipidemia and hypertension

2026-01-30 pharmacology and therapeutics Title + abstract only
View on medRxiv
Show abstract

BackgroundDrug suitability is determined by safety, efficacy, and pathological appropriateness. The pharmacogenomics of drug suitability can be assessed by analyzing drug response and drug choice in large population cohorts. MethodsWe investigated drug response and drug choice for dyslipidemia and hypertension using genetic, phenotypic, and prescribing data from the UK Biobank and the All of Us Research Program. Drug response was reassessed with rigorous biomarker scaling, while genome-wide ass...

Predicted journal destinations